FDA Inspection
IDT Biologika GmbHIDT Biologika GmbH – FDA Inspection, Aug 25, 2023
Record Details
This FDA Inspection record concerns IDT Biologika GmbH, with an inspection on August 25, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- IDT Biologika GmbH
- Inspection Date
- August 25, 2023
- Product Type
- Drugs
View Company Profile
ID · 0fc64664-37e3-4f26-87bd-e7b0a27d1421
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1277176
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of IDT Biologika GmbH
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2026 | Not classified | Office of Inspections and Investigations | Human Cellular, Tissue, and Gene Therapies |
| September 8, 2023 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 10, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2019 | Not classified | Office of Inspections and Investigations | |
| November 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for IDT Biologika GmbH
- FDA Inspection 1335726 - 2026-09-15
- FDA Inspection 1217129 - 2023-09-08
- FDA Inspection 1143607 - 2020-09-10
- FDA Inspection 1084145 - 2019-03-08
- FDA Inspection 994505 - 2016-11-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.